Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders.

Saved in:
Bibliographic Details
Title: Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders.
Authors: Dodd S; Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.; Centre of Youth Mental Health, Department of Psychiatry, University of Melbourne, Parkville, Australia., Skvarc DR; Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.; Deakin University, School of Psychology, Geelong, Australia., Dean OM; Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Parkville, Australia., Anderson A; Department of Endocrinology, University Hospital Geelong, Geelong, Australia., Kotowicz M; Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.; Department of Endocrinology, University Hospital Geelong, Geelong, Australia.; Department of Medicine, The University of Melbourne - Western Health, St Albans, VIC, Australia., Berk M; Deakin University, The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, Australia.; Centre of Youth Mental Health, Department of Psychiatry, University of Melbourne, Parkville, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Kenneth Myer Building, Parkville, Australia.; Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Source: The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2022 May 27; Vol. 25 (5), pp. 387-398.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1469-5111
DOI:10.1093/ijnp/pyac014